Use of standards for monitoring alterations of peptide and protein samples
WO2004097420A1
Method for the detection of a neurological dementia disease associated with a loss of short or long term memory, corresponding prosaas peptide and detection reagents
CA2519129A1
Method for detecting alzheimer's disease and corresponding peptides and detection reagents
EP1553515A1
Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation
EP1522856A1
Method for the detection of a neurological or psychiatric, demential disease, especially Alzheimer's disease by use of cholecystokinin (CCK)-molecules, corresponding substances and detection reagents
EP1515142A1
Mass spectrometry methods for direct phenotyping of factor XIIIA polymorphisms
US7207998B2
Intracorneal lens placement method and apparatus
WO03056341A2
Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
EP1431763A1
Method for detecting a metabolic disease
US7202044B2
Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents
AU2002338348A1
Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
DE10158180A1
Method for the detection of Alzheimer's disease and to differentiate Alzheimer's disease from other dementia diseases, associated peptides and their use
